Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
cells (e.g. CRISPR-Cas9 based knockings and knockouts) C4. Practical knowledge of multi-omics tissue analysis. C5. Proven ability to deliver quality outputs in a timely and efficient manner. C6. Ability
-
, cell culture including CRISPR-based genome editing, molecular and biochemical approaches, imaging, as well as potentially RNASeq and proteomics etc. Personalised management of blood testing for renal
-
the Center for Pediatric Neurological Disease Research (CPNDR) [ https://www.stjude.org/research/initiatives/pediatric-translational-neuroscience-initiative.html ]. The CPNDR is currently recruiting
-
. The successful candidate will integrate molecular biology, plant physiology, and modern molecular breeding techniques (e.g., CRISPR-Cas genome editing, gene pyramiding, association mapping, marker-assisted
-
membrane biophysics. https://labs.utdallas.edu/shukla/ Minimum Education and Experience Ph.D in a related field. Preferred Education and Experience To ensure a strong fit for the role, candidates with
-
Post-Doctoral Position - Genome Editing - (240001FZ) Postdoctoral Position in CRISPR-Based Genome Editing and Neurodegenerative Disorders A postdoctoral position is available in the laboratory of Dr
-
analysis, single-cell RNA-Sequencing, CRISPR genome editing, and general molecular biology techniques. Huntsman Cancer Institute is committed to cancer prevention, care, and survivorship for all communities
-
Apply Now Job Summary An exciting opportunity has been created for an experienced researcher to join the Alumkal Laboratory (https://alumkal.lab.medicine.umich.edu/ ) at the U of M Division of Heme
-
, CRISPR/Cas), is preferred Interest in primary hematopoietic stem and progenitor cell experimentation, (CAR) T cells, and flow cytometry Strong understanding of cell culture techniques and immunological
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
motivated Postdoc to study the tumor microenvironment of genitourinary malignancies, using the latest in single-cell transcriptomic, spatial, and CRISPR technologies. We will provide salary support and